I think BB that is really the whole point, otherwise Artimist is useless as it is not in itself a treatment.
If it isn't substantially better, why bother with it?
No Pharma would touch what is essentially a product that helps the actual product work better unless it actually does so
It has already been proven in 2A anyhoo
- Forums
- ASX - By Stock
- EMS
- phase iii trials complete - data awaited
phase iii trials complete - data awaited, page-2
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist